01/08/2025
3:41 PM | Immedica Pharma AB (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC TO-T | |
01/07/2025
6:15 PM | Beryl Capital Management LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
01/02/2025
2:25 PM | Immedica Pharma AB (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC TO-C | |
12/30/2024
6:11 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
6:11 AM | Marinus Pharmaceuticals (Subject)
| Form SC14D9C | |
12/30/2024
6:00 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
3:02 PM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
2:18 PM | Marinus Pharmaceuticals (Subject)
Nochur Sara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
9:35 AM | Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G/A | |
11/15/2024
7:00 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:39 PM | Marinus Pharmaceuticals (Subject)
Sofinnova Investments, Inc. (Filed by)
| Form SC 13G | |
|
11/14/2024
2:04 PM | Cormorant Asset Management, LP (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
11:24 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
8:34 AM | Avoro Capital Advisors LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/12/2024
8:55 AM | JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/01/2024
7:30 PM | Marinus Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
| Form SC 13G | |
10/31/2024
12:05 PM | FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
10/24/2024
7:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
6:57 AM | Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
6:56 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
7:15 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:00 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:09 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:27 PM | Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:27 PM | Marinus Pharmaceuticals (Issuer)
Silverstein Christine Berni (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:20 PM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:21 PM | Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:21 PM | Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:21 PM | MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:22 PM | Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:23 PM | Austin Charles (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:23 PM | Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:01 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
3:55 PM | Marinus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/24/2024
5:35 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:07 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
4:51 PM | CITADEL ADVISORS LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
04/19/2024
5:04 AM | Marinus Pharmaceuticals (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
04/15/2024
6:32 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
AAPL: Double Your Returns in 24 Hours? (Ad) Trader Chris Pulver is diving deep into the inner workings of Wall Street...
To reveal a trading method he’s kept under wraps for years.
You see…
Thanks to “liquidity levels” which show us Wall Street’s biggest undercover buy orders in real time…
This method has shown the ability to DOUBLE our returns… You can see them—along with the finer details of how his strategy works—on this page right here. |
04/04/2024
7:00 AM | Marinus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/04/2024
7:02 AM | Marinus Pharmaceuticals (Filer)
| Form DEFA14A | |
03/27/2024
10:55 AM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
11:18 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
9:35 AM | Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G | |
02/14/2024
8:04 AM | Avoro Capital Advisors LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
11:13 AM | Marinus Pharmaceuticals (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
12:56 PM | JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024
6:25 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024
10:58 AM | FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
